Skip to content

Input of C11-Choline PET/CT in Localization of Parathyroid Adenoma

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01221896
Enrollment
100
Registered
2010-10-15
Start date
2011-01-31
Completion date
Unknown
Last updated
2010-10-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hyperparathyroidism

Keywords

Localization of a parathyroid adenoma in patients with primary hyperparathyroidism.

Brief summary

The purpose of the study is to determine a possible input of C11-Choline PET/CT in identification and localization of a parathyroid adenoma (PTA). Preoperative localization of a PTA has been previously documented in multiple series, and is usually based on scintigraphy and on US. Currently, the conventional technique for localization of a PTA is a dual-isotope scan with Tc99m-MIBI and Tc99m pertechnetate. This study is acquired over at least 3 hours, includes two i.v. injections and the patient has to stay 15-30 min per acquisition under the camera. In addition, there is no anatomical imaging and further correlation with US is usually recommended. In contrast, PET/CT study with C11-Choline takes as long as 10 min., includes one injection, and provides data of higher resolution of functional (PET) and anatomical imaging (CT). Furthermore, dosimetric data shows that the total effective dose from Tc99mMIBI and Tc99m pertechnetate injection is (without CT): 0.5957 rem; and from C11-Choline injection and CT of a chest is: 0.3128 - 0.8628rem.

Interventions

PROCEDUREC11-Choline PET/CT

Sponsors

Hadassah Medical Organization
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Elevation of a calcium and parathyroid hormone in the serum

Design outcomes

Primary

MeasureTime frame
Improved localization of a parathyroid adenoma

Secondary

MeasureTime frame
Facilitation of detection of the parathyroid adenoma at surgery

Countries

Israel

Contacts

Primary ContactMarina Orevi, MD
marinaor@hadassah.org.il0508946211

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026